BioArctic AB (publ) (BIOA-B.ST)
SEK 170.0
(-0.93%)
SEK 170.0
(-0.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 309.69 Million | -31.63 Million | -140.45 Million | -92.34 Million | 327.16 Million | -200.05 Million |
| Net Income | 229.24 Million | -17.44 Million | -139.72 Million | -85.01 Million | 112.53 Million | 488.79 Million |
| Depreciation & Amortization | 18.42 Million | 14.18 Million | 13.04 Million | 10.92 Million | 9.19 Million | 2.05 Million |
| Deferred income taxes | -39.83 Million | - | -1.82 Million | -12.32 Million | -90.37 Million | - |
| Stock-based compensation | 16.13 Million | 2.76 Million | 1.56 Million | 1.31 Million | 383 Thousand | - |
| Change in working capital | 13.15 Million | 24.91 Million | -5.06 Million | 26.55 Million | 403.78 Million | 50.25 Million |
| Other non-cash items | 72.56 Million | -56.05 Million | -8.46 Million | -33.8 Million | -108.36 Million | -741.16 Million |
| Investing Cash Flow | -507.48 Million | -12.76 Million | -4.41 Million | -12.52 Million | -3.27 Million | -3.08 Million |
| Investments in PPE | -7.44 Million | -12.74 Million | -4.38 Million | -12.47 Million | -3.26 Million | -4.25 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -500.04 Million | -18 Thousand | -27 Thousand | -51 Thousand | -11 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | 1.17 Million |
| Other Investing Activities | -500.04 Million | 1000.00 | 1000.00 | -51 Thousand | -11 Thousand | 1.17 Million |
| Financing Cash Flow | 14.06 Million | -2.8 Million | -7.38 Million | -6.59 Million | -138.5 Million | - |
| Debt repayment | -917 Thousand | -8.79 Million | -7.38 Million | -6.59 Million | -6.41 Million | - |
| Dividends payments | - | - | - | - | -132.09 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.98 Million | 5.98 Million | - | - | - | - |
| Other Financing Activities | -1000.00 | -2.8 Million | -7.38 Million | -6.59 Million | -6.41 Million | - |
| Accounts receivables | -11.97 Million | -2.41 Million | -5.12 Million | 23.08 Million | 433.13 Million | 3.91 Million |
| Accounts payables | 25.13 Million | 27.32 Million | 62 Thousand | 3.47 Million | -29.35 Million | 46.34 Million |
| Inventory | -25.13 Million | -27.32 Million | -62 Thousand | -3.47 Million | - | - |
| Other working capital | 25.13 Million | 27.32 Million | 62 Thousand | 3.47 Million | -1000.00 | 46.34 Million |
| Cash at beginning of period | 805.38 Million | 848.4 Million | 999.94 Million | 1.11 Billion | 917.3 Million | 1.11 Billion |
| Cash at end of period | 611.56 Million | 805.38 Million | 848.4 Million | 999.94 Million | 1.11 Billion | 917.3 Million |
| Capital Expenditure | -7.44 Million | -12.74 Million | -4.38 Million | -12.47 Million | -3.26 Million | -4.25 Million |
| Effect of forex changes on cash | -10.09 Million | 4.19 Million | 723 Thousand | -1.36 Million | 10.07 Million | 10.07 Million |
| Net cash flow / Change in cash | -193.81 Million | -43.01 Million | -151.53 Million | -112.83 Million | 195.46 Million | -193.06 Million |
| Free Cash Flow | 302.25 Million | -44.38 Million | -144.84 Million | -104.81 Million | 323.9 Million | -204.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -68.42 Million | -73.09 Million | 229.24 Million | -87.24 Million | 131.01 Million | -100.86 Million |
| Depreciation & Amortization | - | - | 18.42 Million | 4.84 Million | 4.59 Million | 4.56 Million |
| Deferred income taxes | - | - | -39.83 Million | -16.13 Million | - | - |
| Stock-based compensation | - | - | 16.13 Million | 16.13 Million | - | - |
| Change in working capital | -22.26 Million | -44.54 Million | 13.15 Million | 194.14 Million | -186.91 Million | 17.14 Million |
| Other non-cash items | -3.6 Million | -12.29 Million | 72.56 Million | 15.68 Million | -1.62 Million | 15.33 Million |
| Investing Cash Flow | 95.5 Million | -13.46 Million | -507.48 Million | -204.63 Million | -301.84 Million | -865 Thousand |
| Investments in PPE | - | - | -7.44 Million | -7.44 Million | - | -900 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -500.04 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 95.5 Million | -13.46 Million | -500.04 Million | -197.19 Million | -301.84 Million | 35 Thousand |
| Financing Cash Flow | -1.31 Million | 2.12 Million | 14.06 Million | 1.06 Million | 10.94 Million | 783 Thousand |
| Debt repayment | - | - | -917 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 14.98 Million | - | - | - |
| Other Financing Activities | -1.31 Million | 2.12 Million | -1000.00 | 1.06 Million | 10.94 Million | 783 Thousand |
| Accounts receivables | - | - | -11.97 Million | -11.97 Million | - | - |
| Accounts payables | - | - | 25.13 Million | - | - | - |
| Inventory | - | - | -25.13 Million | - | - | - |
| Other working capital | -22.26 Million | -44.54 Million | 25.13 Million | 206.12 Million | -186.91 Million | 17.14 Million |
| Cash at beginning of period | 491.03 Million | 611.56 Million | 805.38 Million | 697.78 Million | 1.04 Billion | 1.1 Billion |
| Cash at end of period | 489.67 Million | 491.03 Million | 611.56 Million | 611.56 Million | 697.78 Million | 1.04 Billion |
| Capital Expenditure | - | - | -7.44 Million | -7.44 Million | - | -900 Thousand |
| Effect of forex changes on cash | -1.23 Million | 5.21 Million | -10.09 Million | -10.07 Million | -493 Thousand | 16 Thousand |
| Net cash flow / Change in cash | -1.35 Million | -120.53 Million | -193.81 Million | -86.21 Million | -344.32 Million | -63.88 Million |
| Free Cash Flow | -94.29 Million | -114.4 Million | 302.25 Million | 119.98 Million | -52.93 Million | -64.72 Million |
0IPB
ET
ICE
300124
300715
3027